Weekly Dose: Keytruda may be a miracle cancer drug, but can those who need it afford it?
- Written by Nicholas Huntington, Laboratory Head, Molecular Immunology, Walter and Eliza Hall Institute
Immunotherapy works by increasing the magnitude or quality of the patient's own immune response.from shutterstock.com
Keytruda (generic name pembrolizumab) is an immunotherapy drug manufactured by the company Merck & Co. It is most commonly used to treat melanoma, and was listed for this use by Australia’s Therapeutic Goods Administration...
Read more: Weekly Dose: Keytruda may be a miracle cancer drug, but can those who need it afford it?